Skip to content
Research Article Open access CC BY 3.0

Block Copolymer Crosslinked Nanoassemblies Co-Entrapping Acridine Yellow and Doxorubicin for Cancer Theranostics

Pengxiao Cao, Andrei Ponta, JiAe Kim, Younsoo Bae

Journal of Pharmaceutical Research International · pp. 523–535 · Published 15 May 2013

10.9734/BJPR/2013/4574

Abstract

Aims: To develop block copolymer crosslinked nanoassemblies (CNAs) that co-entrap an imaging dye (Acridine Yellow: AY) and therapeutic agent (doxorubicin: DOX) as novel nanoparticle drug carriers for a combined application of drug delivery-based therapy and diagnostic imaging technologies (theranostics). Study Design: Physicochemical properties of AY-CNAs, such as molecular weight, particle size, surface charge, drug entrapment yield, and drug release profiles, were characterized prior to determining intracellular uptake profile, in vitro cytotoxicity, and in vivo tissue distribution patterns of the particles. Place and Duration of Study: Department of Pharmaceutical Sciences (University of Kentucky), between June 2012 and January 2013. Methodology: The AY-crosslinked CNAs (CNAs) were synthesized from biocompatible poly(ethylene glycol)-poly(aspartate) block copolymers by using AY as a crosslinker while DOX was physically entrapped in the particle through an ionic interaction. AY-CNAs and AY-CNAs with DOX were characterized to determine their particle properties (molecular weight, size, and optical properties), intracellular uptake and cytotoxicity in an in vitro cell culture system using human colon HT29 and lung A549 cancer cell lines, and tissue accumulation and tumor-preferential drug delivery efficiency ex vivo with a xenograft mouse tumor model. Results: AY-CNAs maintained nanoscale particle sizes (< 20 nm), fluorescence optical properties, and negative surface charge before and after drug entrapment. AY-CNAs with DOX were confirmed to kill cancer cells as effectively as free drug formulations, and to enhance intracellular uptake in vitro and tumor accumulation ex vivo. Conclusion: These results demonstrate that block copolymer nanoassemblies crosslinked with an imaging dye are promising platforms for the development of theranostic nanoparticle drug carriers.

Nanoparticles nanoassemblies drug carriers drug delivery imaging theranostics

References (32)

  1. 1 Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles [DOI]
  2. 2 Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging [DOI]
  3. 3 Nanoparticle-based theranostic agents [DOI]
  4. 4 Design of Environment‐Sensitive Supramolecular Assemblies for Intracellular Drug Delivery: Polymeric Micelles that are Responsive to Intracellular pH Change [DOI]
  5. 5 Imaging and drug delivery using theranostic nanoparticles [DOI]
  6. 6 Multimodality Imaging Probes: Design and Challenges [DOI]
  7. 7 Theranostic Nanomedicine [DOI]
  8. 8 Trends in the exploitation of novel drug targets [DOI]
  9. 9 Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers [DOI]
  10. 10 Polymeric Conjugates for Drug Delivery [DOI]
  11. 11 Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery [DOI]
  12. 12 Acid-degradable polymers for drug delivery: a decade of innovation [DOI]
  13. 13 The Effects of Size, Shape, and Surface Functional Group of Gold Nanostructures on Their Adsorption and Internalization by Cells [DOI]
  14. 14 Envisioning the future of early anticancer drug development [DOI]
  15. 15 Nanotechnology in Medical Imaging [DOI]
  16. 16 Design of Environment‐Sensitive Supramolecular Assemblies for Intracellular Drug Delivery: Polymeric Micelles that are Responsive to Intracellular pH Change [DOI]
  17. 17 Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy [DOI]
  18. 18 Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes [DOI]
  19. 19 Nanoparticulate Alternatives for Drug Delivery [DOI]
  20. 20 A Novel Clinically Translatable Fluorescent Nanoparticle for Targeted Molecular Imaging of Tumors in Living Subjects [DOI]
  21. 21 Cross-Linked Nanoassemblies from Poly(ethylene glycol)-poly(aspartate) Block Copolymers as Stable Supramolecular Templates for Particulate Drug Delivery [DOI]
  22. 22 Pharmaceutical Differences Between Block Copolymer Self-Assembled and Cross-Linked Nanoassemblies as Carriers for Tunable Drug Release [DOI]
  23. 23 Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry [DOI]
  24. 24 Multifunctional Magnetoplasmonic Nanoparticle Assemblies for Cancer Therapy and Diagnostics (Theranostics) [DOI]
  25. 25 NANOPARTICLES: A BOON TO DRUG DELIVERY, THERAPEUTICS, DIAGNOSTICS AND IMAGING, NANOMEDICINE: NANOTECHNOLOGY
  26. 26 In vivomolecular imaging using nanomaterials: Generalin vivocharacteristics of nano-sized reagents and applications for cancer diagnosis (Review) [DOI]
  27. 27 Biomaterials and Drug Delivery: Past, Present, and Future [DOI]
  28. 28 Polymer Nanoassemblies for Cancer Treatment and Imaging [DOI]
  29. 29 Disease-Responsive Drug Delivery: The Next Generation of Smart Delivery Devices [DOI]
  30. 30 Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788 [DOI]
  31. 31 Closing the Ring to Bring Up the Light: Synthesis of a Hexacyclic Acridinium Cyanine Dye [DOI]
  32. 32 Nanodrug potential in cancer therapy: efficacy/toxicity studies in cancer cells [DOI]

Cited by 7

Light-Sensitive Ruthenium Complex-Loaded Cross-linked Polymeric Nanoassemblies for the Treatment of Cancer

Matthew Dickerson, B. Howerton, Y. Bae · Journal of materials chemistry. B · 2015

Showing 5 of 7 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

34

Page views

0

PDF downloads

11

Outbound clicks

7

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.